T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
EXL Service
EXLS
$5.22B
| $53.9M | 0.01% |
1,717,244
-356,561
| -17% | -$10.7M |
|
702
Willis Towers Watson
WTW
$31B
| $53.9M | 0.01% |
205,425
+50,452
| +33% | +$13M |
|
703
Performance Food Group
PFGC
$16.4B
| $53.7M | 0.01% |
812,936
-241,689
| -23% | -$16.8M |
|
704
Sarepta Therapeutics
SRPT
$1.94B
| $53.7M | 0.01% |
340,030
-164,938
| -33% | -$21.2M |
|
705
Lennar Class A
LEN
$21B
| $53.4M | 0.01% |
368,079
+5,509
| +2% | +$838K |
|
706
Guidewire Software
GWRE
$14.6B
| $53.1M | 0.01% |
385,439
+340,455
| +757% | +$41M |
|
707
Hamilton Lane
HLNE
$5.76B
| $53.1M | 0.01% |
429,703
+34,897
| +9% | +$4.08M |
|
708
Dow Inc
DOW
$21.9B
| $52.7M | 0.01% |
993,407
+33,887
| +4% | +$1.94M |
|
709
Dick's Sporting Goods
DKS
$18.1B
| $52.6M | 0.01% |
244,955
-5,003
| -2% | -$1.04M |
|
710
Denali Therapeutics
DNLI
$4.03B
| $52.4M | 0.01% |
2,255,470
+661,137
| +41% | +$12.7M |
|
711
Align Technology
ALGN
$12.3B
| $52.3M | 0.01% |
216,805
-220,414
| -50% | -$61.4M |
|
712
Option Care Health
OPCH
$3.61B
| $52.3M | 0.01% |
1,887,947
+127,465
| +7% | +$3.8M |
|
|
COOP
713
DELISTED
Mr. Cooper
COOP
| $52.2M | 0.01% |
643,160
+252,203
| +65% | +$20.3M |
|
|
CRGX
714
DELISTED
CARGO Therapeutics
CRGX
| $52.2M | 0.01% |
3,178,071
+84,724
| +3% | +$1.61M |
|
715
TKO Group
TKO
$14.4B
| $52M | 0.01% |
481,857
+90,980
| +23% | +$9.24M |
|
716
Public Service Enterprise Group
PEG
$37.8B
| $51.9M | 0.01% |
704,508
+25,672
| +4% | +$1.82M |
|
717
Q2 Holdings
QTWO
$3.95B
| $51M | 0.01% |
845,326
+125,559
| +17% | +$7.21M |
|
718
General Mills
GIS
$20.6B
| $51M | 0.01% |
805,632
+18,631
| +2% | +$1.28M |
|
719
Omnicom Group
OMC
$23.8B
| $50.9M | 0.01% |
567,848
-230,227
| -29% | -$21.4M |
|
720
Disc Medicine
IRON
$3.07B
| $50.6M | 0.01% |
1,122,194
+177,981
| +19% | +$6.05M |
|
721
VanEck Oil Services ETF
OIH
$1.95B
| $50.6M | 0.01% |
159,877
-635
| -0.4% | -$203K |
|
722
Atlas Energy Solutions
AESI
$1.48B
| $50.4M | 0.01% |
2,528,502
+900,017
| +55% | +$20.1M |
|
|
EXAS
723
DELISTED
Exact Sciences
EXAS
| $50.1M | 0.01% |
1,185,123
-160,115
| -12% | -$8.81M |
|
724
ON Semiconductor
ON
$32.4B
| $50M | 0.01% |
729,510
-284,309
| -28% | -$19.9M |
|
725
Axalta
AXTA
$7.95B
| $49.8M | 0.01% |
1,458,691
+5,058
| +0.3% | +$173K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.